Approach to Neck Lymphadenitis
If the neck mass shows clear signs of bacterial infection (warmth, erythema, localized swelling, tenderness, fever), prescribe a single course of broad-spectrum antibiotics covering Staphylococcus aureus and Streptococcus pyogenes, but mandate reassessment within 2 weeks—if not completely resolved, immediately pursue malignancy workup regardless of partial improvement. 1
Initial Clinical Assessment: Distinguish Infectious from Malignant
Signs Suggesting Bacterial Infection
- Local findings: warmth, erythema of overlying skin, localized swelling, and tenderness to palpation 1
- Systemic findings: fever, tachycardia, rhinorrhea, odynophagia, otalgia, or odontalgia 1
- Temporal relationship: mass developed within days/weeks of upper respiratory infection, dental problem, trauma (including insect bites), travel, or animal exposure 1
Red Flags for Malignancy (Immediate Advanced Workup Required)
- Duration: present ≥2 weeks without significant fluctuation OR uncertain duration 1
- Physical characteristics: fixation to adjacent tissues, firm consistency, size >1.5 cm, or ulceration of overlying skin 1
- Location: supraclavicular or posterior cervical nodes carry much higher malignancy risk than anterior cervical nodes 2
- Demographics: age >40 years, male sex, white race 3
- Absence of infectious etiology 1
Critical Diagnostic Algorithm
Step 1: History and Physical Examination
Perform targeted examination including: 1
- Skin and scalp (cutaneous malignancy)
- Otoscopy (unilateral serous otitis suggests nasopharyngeal malignancy)
- Complete cranial nerve assessment
- Oral cavity with digital examination of tongue and floor of mouth
- Oropharynx with palpation of tongue base and tonsillar fossae
- Nasopharynx, hypopharynx, and larynx visualization
- Bimanual palpation of floor of mouth and entire neck
- Salivary glands and thyroid palpation
Step 2: Laboratory Testing
- If infectious suspected: white blood cell count and C-reactive protein (elevated in 94% of bacterial cases) 4
- If mycobacterial suspected: tuberculin skin test (PPD), chest radiograph 2, 5
- If persistent/suspicious: complete blood count, erythrocyte sedimentation rate, tuberculosis testing 6
Step 3: Imaging
- Ultrasound: first-line to differentiate bacterial lymphadenitis (single node with hypoechoic core) from other etiologies; 87.5% correlation with clinical/surgical findings 4
- CT with contrast: if ultrasound inconclusive or to characterize adenopathy and assess for retropharyngeal edema/phlegmon 5
- MRI: if CT contraindicated 1
Step 4: Tissue Diagnosis
- Fine-needle aspiration (FNA): for cytology and culture when malignancy or mycobacterial infection suspected 1, 5
- Core needle or excisional biopsy: if FNA non-diagnostic 6, 3
Treatment Based on Etiology
Bacterial Lymphadenitis (Acute Unilateral)
- Antibiotic choice: broad-spectrum covering S. aureus and S. pyogenes (40-80% of acute unilateral cases) 7
- Duration: single course 1
- Surgical drainage: indicated if suppurative/abscess formation (29.4% of cases require incision and drainage) 4
- Mandatory follow-up: reassess within 2 weeks; if not completely resolved, pursue malignancy workup 1
- Additional follow-up: if resolved, reassess again in 2-4 weeks to monitor for recurrence (which mandates malignancy workup) 1
Mycobacterial Lymphadenitis
Critical distinction required: 2, 5, 8
Nontuberculous Mycobacteria (NTM)
- Demographics: primarily children aged 1-5 years; 80% caused by Mycobacterium avium complex 2
- Treatment: complete surgical excision without chemotherapy (95% success rate) 5
- Avoid: incisional biopsy or drainage alone—leads to sinus tract formation and chronic drainage 2, 5
Mycobacterium tuberculosis
- Demographics: >90% of mycobacterial lymphadenitis in adults 2, 5
- Treatment: systemic antituberculosis medication (treat as systemic disease) 8
- Public health: requires reporting and contact tracing 2
- PPD interpretation: ≥15 mm in child with granulomatous adenitis suggests tuberculosis; start treatment while awaiting culture 5
Viral Lymphadenopathy
- Most common cause: upper respiratory tract infections (22-53% of cases) 2
- Specific pathogens: Epstein-Barr virus, Cytomegalovirus, Coxsackievirus, Rubella 2
- Management: self-limited; typically resolves with infectious symptoms or within days of completing treatment 1
Special Population Considerations
HIV/Immunocompromised Patients
- Disseminated MAC: common with CD4 <50 cells/μL, causes suppurative lymphadenopathy 2
- Immune reconstitution inflammatory syndrome: paradoxical lymphadenitis after starting antiretroviral therapy 2, 5
- Cytomegalovirus: high mortality if misdiagnosed 2
Children
- Kawasaki disease: consider if cervical lymphadenopathy ≥1.5 cm with fever ≥5 days plus ≥4 principal features (oral changes, conjunctival injection, rash, extremity changes) 1
- Distinguish from bacterial: multiple enlarged nodes with retropharyngeal edema in Kawasaki vs. single node with hypoechoic core in bacterial lymphadenitis 1
Critical Pitfalls to Avoid
- Never use empiric antibiotics without infectious signs/symptoms—delays malignancy diagnosis 1
- Partial resolution on antibiotics may represent infection in underlying malignancy—requires full workup 1
- Avoid corticosteroids—masks histologic diagnosis of lymphoma 6, 3
- Do not perform incisional biopsy for suspected mycobacterial disease—causes chronic fistula formation 2, 5
- Distinguish TB from NTM before treatment—TB requires drug therapy and public health tracking; NTM requires surgical excision 2
- Supraclavicular and epitrochlear nodes are abnormal—mandate aggressive workup for malignancy 6, 3